Immunopathogenesis of Chlamydial Infections
- PMID: 27370346
- PMCID: PMC6086136
- DOI: 10.1007/82_2016_18
Immunopathogenesis of Chlamydial Infections
Abstract
Chlamydial infections lead to a number of clinically relevant diseases and induce significant morbidity in human populations. It is generally understood that certain components of the host immune response to infection also mediate such disease pathologies. A clear understanding of pathogenic mechanisms will enable us to devise better preventive and/or intervention strategies to mitigate the morbidity caused by these infections. Over the years, numerous studies have been conducted to explore the immunopathogenic mechanisms of Chlamydia-induced diseases of the eye, reproductive tract, respiratory tract, and cardiovascular systems. In this article, we provide an overview of the diseases caused by Chlamydia, animal models used to study disease pathology, and a historical context to the efforts to understand chlamydial pathogenesis. Furthermore, we discuss recent findings regarding pathogenesis, with an emphasis on the role of the adaptive immune response in the development of chlamydial disease sequelae. Finally, we summarize the key insights obtained from studies of chlamydial pathogenesis and avenues that remain to be explored in order to inform the next steps of vaccine development against chlamydial infections.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Pathogenesis of fallopian tube damage caused by Chlamydia trachomatis infections.Contraception. 2015 Aug;92(2):108-15. doi: 10.1016/j.contraception.2015.01.004. Epub 2015 Jan 13. Contraception. 2015. PMID: 25592078 Review.
-
Chlamydial hsp60 and the immunopathogenesis of chlamydial disease.Semin Immunol. 1991 Jan;3(1):25-33. Semin Immunol. 1991. PMID: 1680011 Review.
-
Immunopathogenesis of genital Chlamydia infection: insights from mouse models.Pathog Dis. 2021 Mar 31;79(4):ftab012. doi: 10.1093/femspd/ftab012. Pathog Dis. 2021. PMID: 33538819 Free PMC article. Review.
-
Chlamydia trachomatis: Protective Adaptive Responses and Prospects for a Vaccine.Curr Top Microbiol Immunol. 2018;412:217-237. doi: 10.1007/82_2016_6. Curr Top Microbiol Immunol. 2018. PMID: 27033698 Review.
-
Chlamydial protease-like activity factor--insights into immunity and vaccine development.J Reprod Immunol. 2009 Dec;83(1-2):179-84. doi: 10.1016/j.jri.2009.05.007. Epub 2009 Oct 23. J Reprod Immunol. 2009. PMID: 19853923 Free PMC article. Review.
Cited by
-
A VCG-Based Multiepitope Chlamydia Vaccine Incorporating the Cholera Toxin A1 Subunit (MECA) Confers Protective Immunity Against Transcervical Challenge.Biomedicines. 2025 Jan 24;13(2):288. doi: 10.3390/biomedicines13020288. Biomedicines. 2025. PMID: 40002702 Free PMC article.
-
A Minimal Replicon Enables Efficacious, Species-Specific Gene Deletion in Chlamydia and Extension of Gene Knockout Studies to the Animal Model of Infection Using Chlamydia muridarum.Infect Immun. 2022 Dec 15;90(12):e0045322. doi: 10.1128/iai.00453-22. Epub 2022 Nov 9. Infect Immun. 2022. PMID: 36350146 Free PMC article.
-
The Chlamydia pneumoniae inclusion membrane protein Cpn0308 interacts with host protein ACBD3.J Bacteriol. 2025 Jan 31;207(1):e0027524. doi: 10.1128/jb.00275-24. Epub 2024 Dec 26. J Bacteriol. 2025. PMID: 39723831 Free PMC article.
-
Human umbilical cord mesenchymal stem cells derived extracellular vesicles alleviate salpingitis by promoting M1-to-M2 transformation.Front Physiol. 2023 Feb 16;14:1131701. doi: 10.3389/fphys.2023.1131701. eCollection 2023. Front Physiol. 2023. PMID: 36875046 Free PMC article.
-
The Reaction of Innate Lymphoid Cells in the Mouse Female Genital Tract to Chlamydial Infection.Infect Immun. 2021 Oct 15;89(11):e0080020. doi: 10.1128/IAI.00800-20. Epub 2021 Aug 23. Infect Immun. 2021. PMID: 34424753 Free PMC article.
References
-
- Andrew DW, Cochrane M, Schripsema JH, Ramsey KH, Dando SJ, O’Meara CP, Timms P, Beagley KW. The duration of Chlamydia muridarum genital tract infection and associated chronic pathological changes are reduced in IL-17 knockout mice but protection is not increased further by immunization. PLoS One. 2013;8:e76664. - PMC - PubMed
-
- Bai H, Cheng J, Gao X, Joyee AG, Fan Y, Wang S, Jiao L, Yao Z, Yang X. IL-17/Th17 promotes type 1. T cell immunity against pulmonary intracellular bacterial infection through modulating dendritic cell function. J Immunol. 2009;183:5886–5895. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical